USPTO serial 88223789
ENGILITY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 11, 2020
- Examiner
- MIRANDA, JOHN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
Need help with ENGILITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
PharmaSEAL International Limited
Nottingham, GB
PharmaSEAL International Limited
Nottingham, GB
PharmaSEAL International Limited
Nottingham, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Molly B. Markley
Molly B. Markley YOUNG, BASILE, HANLON & MACFARLANE P.C.3001 WEST BIG BEAVER ROADSUITE 624TROY, MI 48084-3107Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [Computer software for use in the field of clinical research and clinical trials; computer software for use in clinical research and clinical trials; software for use in the collection and management of clinical data; computer software for the collection, entry, analysis, management and validation of clinical research and clinical trial data; computer software for managing clinical trial data and information; computer software for use in the remote or local collection of clinical trial data; computer software for use in clinical trial design and development; computer software for use in clinical trial planning and management; computer software for use in clinical trial patient randomisation; computer software for use in clinical trial patient monitoring; computer software for use in clinical trial data management and analysis] | SECTION 8 - CANCELLED | — |
| 042 | Software as a services (SaaS) featuring software for clinical research and clinical trials; software as a services (SaaS) featuring software for management of clinical trials; software as a services (SaaS) featuring software for clinical testing; providing online non-downloadable software for clinical research and clinical trials; providing online non-downloadable software for management of clinical trials; customisation of software for use in clinical research or clinical trials; customisation of software for clinical testing; [consulting services for others for clinical research, trials and scientific testing in the field of radiology; ] information, advisory and consultancy services in relation to the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PharmaSEAL International Limited
- Other trademarks owned by PharmaSEAL International Limited
- Other trademarks owned by PharmaSEAL International Limited
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named ENGILITY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| May 12, 2026 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| May 4, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 11, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Feb 11, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 11, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 17, 2019 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Oct 11, 2019 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Oct 7, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 23, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 10, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 13, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 2, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 13, 2018 | NWAP | NEW APPLICATION ENTERED | — |